Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Jacob K Sont"'
Publikováno v:
JMIR Pediatrics and Parenting, Vol 4, Iss 4, p e17959 (2021)
BackgroundInternet-based self-management programs improve asthma control and the asthma-related quality of life in adults and adolescents. The components of self-management programs include education and the web-based self-monitoring of symptoms; the
Externí odkaz:
https://doaj.org/article/6183430c10c64864be1fceb1cae1a125
Autor:
Jiska B Snoeck-Stroband, Therese S Lapperre, Peter J Sterk, Pieter S Hiemstra, Henk A Thiadens, H Marike Boezen, Nick H T Ten Hacken, Huib A M Kerstjens, Dirkje S Postma, Wim Timens, Jacob K Sont, GLUCOLD Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0143793 (2015)
BACKGROUND:The decline in lung function can be reduced by long-term inhaled corticosteroid (ICS) treatment in subsets of patients with chronic obstructive pulmonary disease (COPD). We aimed to identify which clinical, physiological and non-invasive i
Externí odkaz:
https://doaj.org/article/1513374b1de047b49a3310d10aadad64
Autor:
Victor van der Meer, Wilbert B van den Hout, Moira J Bakker, Klaus F Rabe, Peter J Sterk, Willem J J Assendelft, Job Kievit, Jacob K Sont, SMASHING (Self-Management in Asthma Supported by Hospitals, ICT, Nurses and General Practitioners) Study Group
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27108 (2011)
BackgroundEffectiveness of Internet-based self-management in patients with asthma has been shown, but its cost-effectiveness is unknown. We conducted a cost-effectiveness analysis of Internet-based asthma self-management compared with usual care.Meth
Externí odkaz:
https://doaj.org/article/4d32f234390944aba18b31c997e5f51e
Autor:
Stefania Principe, Levi B. Richards, Simone Hashimoto, Johannes Anthon Kroes, Job J.M.H. Van Bragt, Susanne J. Vijverberg, Jacob K. Sont, Nicola Scichilone, Kristina Bieksiene, Anneke Ten Brinke, Zsuzsanna Csoma, Barbro Dahlén, Bilun Gemicioglu, Ineta Grisle, Piotr Kuna, Zorica Lazic, Florin Mihaltan, Sanja Popović-Grle, Sabina Škrgat, Alessandro Marcon, Marco Caminati, Ratko Djukanovic, Celeste Porsbjerg, Anke-Hilse Maitland Van Der Zee
Publikováno v:
ERJ Open Research. 9:00586-2022
BackgroundThe use of anti-interleukin-5 (IL5) for severe asthma is based on criteria from randomised controlled trials (RCTs), but in real-life patients might not fulfil the eligibility criteria but may benefit from biologics. We aimed to characteris
Autor:
Johannes A. Kroes, Kim de Jong, Simone Hashimoto, Sander W. Zielhuis, Eric N. van Roon, Jacob K. Sont, Anneke ten Brinke
Publikováno v:
ERJ Open Research. 9:00559-2022
BackgroundBenralizumab is highly effective in many, but not all, patients with severe asthma. Baseline characteristics alone are insufficient to predict an individual's probability of long-term benralizumab response. The objectives of the present stu
Autor:
Johannes A. Kroes, Rafael Alfonso-Cristancho, Aruna T. Bansal, Emmanuelle Berret, Kristina Bieksiene, Arnaud Bourdin, Luisa Brussino, Diogo Canhoto, Cristina Cardini, Gulfem Celik, Zsuzsanna Csoma, Barbro Dahlén, Ebru Damadoglu, Katrien Eger, Lisa Gauquelin, Bilun Gemicioglu, Ozlem Goksel, Sophie Graff, Enrico Heffler, Hendrik B. Hofstee, Peter Howarth, Rupert W. Jakes, Fabienne Jaun, Virginija Kalinauskaite-Zukauske, Peter Kopač, Namhee Kwon, Claudia C. Loureiro, Victor Lozoya García, Matthew Masoli, Mariana Paula Rezelj, Luis Pérez De Llano, Sanja Popović-Grle, David Ramos-Barbón, Ana Sà Sousa, Konstantinos Samitas, Florence Schleich, Concetta Sirena, Sabina Skrgat, Eleftherios Zervas, George Zichnalis, Elisabeth H. Bel, Jacob K. Sont, Simone Hashimoto, Anneke Ten Brinke
Publikováno v:
ERJ Open Research, 9(2):00745-2022. BMJ Publishing Group
Kroes, J A, Alfonso-Cristancho, R, Bansal, A T, Berret, E, Bieksiene, K, Bourdin, A, Brussino, L, Canhoto, D, Cardini, C, Celik, G, Csoma, Z, Dahlén, B, Damadoglu, E, Eger, K, Gauquelin, L, Gemicioglu, B, Goksel, O, Graff, S, Heffler, E, Hofstee, H B, Howarth, P, Jakes, R W, Jaun, F, Kalinauskaite-Zukauske, V, Kopač, P, Kwon, N, Loureiro, C C, García, V L, Masoli, M, Rezelj, M P, de Llano, L P R, Popović-Grle, S, Ramos-Barbón, D, Sousa, A S, Samitas, K, Schleich, F, Sirena, C, Skrgat, S, Zervas, E, Zichnalis, G, Bel, E H, Sont, J K, Hashimoto, S & Brinke, A T 2023, ' Evaluation of real-world mepolizumab use in severe asthma across Europe : the SHARP experience with privacy-preserving federated analysis ', ERJ Open Research, vol. 9, no. 2, 00745-2022 . https://doi.org/10.1183/23120541.00745-2022
Kroes, J A, Alfonso-Cristancho, R, Bansal, A T, Berret, E, Bieksiene, K, Bourdin, A, Brussino, L, Canhoto, D, Cardini, C, Celik, G, Csoma, Z, Dahlén, B, Damadoglu, E, Eger, K, Gauquelin, L, Gemicioglu, B, Goksel, O, Graff, S, Heffler, E, Hofstee, H B, Howarth, P, Jakes, R W, Jaun, F, Kalinauskaite-Zukauske, V, Kopač, P, Kwon, N, Loureiro, C C, García, V L, Masoli, M, Rezelj, M P, de Llano, L P R, Popović-Grle, S, Ramos-Barbón, D, Sousa, A S, Samitas, K, Schleich, F, Sirena, C, Skrgat, S, Zervas, E, Zichnalis, G, Bel, E H, Sont, J K, Hashimoto, S & Brinke, A T 2023, ' Evaluation of real-world mepolizumab use in severe asthma across Europe : the SHARP experience with privacy-preserving federated analysis ', ERJ Open Research, vol. 9, no. 2, 00745-2022 . https://doi.org/10.1183/23120541.00745-2022
BackgroundAn objective of the Severe Heterogeneous Asthma Registry, Patient-centered (SHARP) is to produce real-world evidence on a pan-European scale by linking nonstandardised, patient-level registry data. Mepolizumab has shown clinical efficacy in
Autor:
Rik Loijmans, Jacob K. Sont, Suzanne Boer, Persijn J. Honkoop, Willem J J Assendelft, Tjard Schermer, Jiska B. Snoeck-Stroband
Publikováno v:
Huisarts en wetenschap, 64(5), 28-33. Bohn Stafleu van Loghum
Bij de monitoring van patienten met astma wordt momenteel vooral gekeken naar symptomen en de longfunctie, en niet naar de ernst van de onderliggende inflammatie. Toch kan het meten van de ontsteking nuttig zijn voor een subgroep van astmapatienten.
Autor:
Merel M Ruissen, Jacob K Sont, Heidi A van Vugt, Marleen Kunneman, Guy EHM Rutten, Eelco JP de Koning
Publikováno v:
Patient Preference and Adherence, 16, 809-819. DOVE MEDICAL PRESS LTD
Merel M Ruissen,1â 3 Jacob K Sont,2 Heidi A van Vugt,4,5 Marleen Kunneman,2,3 Guy EHM Rutten,4 Eelco JP de Koning1 1Department of Medicine, Leiden University Medical Centre, Leiden, the Netherlands; 2Department of Biomedical Data Sciences, Secti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837202b896d3486f07cfb04b70338d35
https://doi.org/10.2147/ppa.s354686
https://doi.org/10.2147/ppa.s354686
Autor:
Claire D. Visser, Jip M. Linthorst, Esther Kuipers, Jacob K. Sont, Joyca P. W. Lacroix, Henk-Jan Guchelaar, Martina Teichert
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, 12. FRONTIERS MEDIA SA
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, 12. FRONTIERS MEDIA SA
Introduction: Suboptimal self-management of inhaled corticosteroids (ICS) in asthma patients is frequently observed in clinical practice and associated with poor asthma control. Driving factors for suboptimal self-management are complex and consist o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4aeed76f2a2a827374eb8c840b0701d4
https://doi.org/10.3389/fphar.2021.767092
https://doi.org/10.3389/fphar.2021.767092
Autor:
Felix Strohmeier, Javier Delgado-Lista, Gustavo Rodríguez Suárez, Dietmar Glachs, Albert A de Graaf, Michel Sluis, Jacob K. Sont, Tuncay Namli, Eckhard Salzsieder, Lutz Vogt
Publikováno v:
MIE
The main objective of POWER2DM is to develop and validate a personalized self-management support system (SMSS) for T1 and T2 diabetes patients that combines and integrates i) a decision support system (DSS) based on leading European predictive person
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1535090cb00fbf2017b22ad0b993a562
https://doi.org/10.3233/shti210321
https://doi.org/10.3233/shti210321